By Rachel M. Cohen The Intercept
Leaders wrestle over whether requiring student Covid shots will politicize other pediatric vaccines and embolden vaccine opponents.
It wasn’t supposed to take this long to fully approve Covid-19 vaccines for the nearly 17 million U.S. adolescents ages 12-15 and the 28 million children ages 5-11.
Back in early August, Lee Beers, the president of the American Academy of Pediatrics, sent a letter to the U.S. Food and Drug Administration urging the agency to move faster and questioning its request for extra follow-up data before emergency authorization. “We urge the FDA to carefully consider the impact of this decision on the timeline for authorizing a vaccine,” Beers wrote. “There is no biological plausibility for serious adverse immunological or inflammatory events to occur more than two months after COVID-19 vaccine administration.”
New York Times columnist Michelle Goldberg put the situation more bluntly. “The problem is that the F.D.A. won’t be blamed for avoidable Covid cases the same way it would be blamed for unexpected vaccine side effects,” she wrote. “All of its institutional incentives therefore point toward excessive wariness.”
Leave a Reply